| Review on chemistry and therapeutic activity of the derivatives of furan and oxazole: the oxygen containing heterocycles EM Rymbai, A Chakraborty, R Choudhury, N Verma, B De Der Pharma Chemica 11 (1), 20-41, 2019 | 22 | 2019 |
| Evaluation of anti-inflammatory and anti-arthritic property of ethanolic extract of Clitoria ternatea KP Swathi, S Jayaram, D Sugumar, E Rymbai Chinese Herbal Medicines 13 (2), 243-249, 2021 | 19 | 2021 |
| Ropinirole, a potential drug for systematic repositioning based on side effect profile for management and treatment of Breast Cancer E Rymbai, D Sugumar, J Saravanan, S Divakar Medical Hypotheses 144, 110156, 2020 | 9 | 2020 |
| An Update on the Role of Nrf2 and its Activators in Diseases Associated with Oxidative Stress. D Sugumar, J Saravanan, R Emdormi, TK Praveen Indian Journal of Pharmaceutical Sciences 82 (2), 2020 | 9 | 2020 |
| Importance of fibrosis in the pathogenesis of uterine leiomyoma and the promising anti-fibrotic effects of dipeptidyl peptidase-4 and fibroblast activation protein inhibitors … AS Bhat, NA Singh, E Rymbai, S Birendra, S Jayaram, D Selvaraj Reproductive Sciences 30 (5), 1383-1398, 2023 | 6 | 2023 |
| Evaluation of aphrodisiac activity of Allium sativum in male rats PV Warange, J Saravanan, TK Praveen, E Rymbai, S Deepa Int. J. Sci. Technol. Res 8, 1683-1686, 2019 | 6 | 2019 |
| Neuroprotective effects of farnesol on motor and cognitive impairment against 3-nitropropionic acid-induced Huntington's disease. S Deepa, E Rymbai, TK Praveen, J Saravanan Thai Journal of Pharmaceutical Sciences 45 (1), 16-23, 2021 | 5 | 2021 |
| Evaluation of anti-cancer, antioxidant and antimicrobial activities of Alstonia scholaris L R Nanditha, J Saravanan, TK Praveen, S Deepa, E Rymbai Research Journal of Pharmacy and Technology 13 (9), 4153-4157, 2020 | 5 | 2020 |
| Phosphodiesterase-4 inhibition in Parkinson’s disease: molecular insights and therapeutic potential D Roy, S Balasubramanian, PT Krishnamurthy, P Sola, E Rymbai Cellular and Molecular Neurobiology 43 (6), 2713-2741, 2023 | 4 | 2023 |
| The identification of c-Abl inhibitors as potential agents for Parkinson’s disease: a preliminary in silico approach E Rymbai, D Roy, S Jupudi, V Srinivasadesikan Molecular Diversity, 1-15, 2024 | 1 | 2024 |
| The identification of cianidanol as a selective estrogen receptor beta agonist and evaluation of its neuroprotective effects on Parkinson's disease models E Rymbai, D Sugumar, A Chakkittukandiyil, R Kothandan, J Selvaraj, ... Life Sciences 333, 122144, 2023 | 1 | 2023 |
| Side effects based network construction and drug repositioning of ropinirole as a potential molecule for Alzheimer’s disease: an in-silico, in-vitro, and in-vivo study A Chakkittukandiyil, S Chakraborty, R Kothandan, E Rymbai, SK Muthu, ... Journal of Biomolecular Structure and Dynamics, 1-15, 2023 | 1 | 2023 |
| Nuclear receptors and other molecular targets in type 2 diabetes mellitus D Sugumar, E Rymbai, S Vasu, D Selvaraj Journal of Applied Pharmaceutical Science 13 (7), 85-101, 2023 | 1 | 2023 |
| The Promotion of Antioxidant and Anti-Inflammatory Activity by Nrf2 Amplifier is A Potential Technique in Diabetic Wound Healing—A Review T Mohanasundaram, V Ramachandran, B Bhongiri, E Rymbai, RM Xavier, ... Pharmaceutical Sciences 29 (3), 255-262, 2022 | 1 | 2022 |
| Temporal Unpredictability and Probabilistic Uncertainty Induced Anxiety in the Times of COVID-19 Pandemic S Jayaram, PT Krishnamurthy, D Selvaraj, SV Nemani, E Rymbai, ... Indian Journal of Pharmaceutical Education and Research 56 (2), 321-328, 2022 | 1 | 2022 |
| Using Link and Major System of Memory to Memorise, Remember and Recall Pharmaceutical Sciences Better S Jayaram, SK Ramajayam, E Rymbai, D Sugumar | 1 | 2020 |
| Drug Repurposing: A Paradigm Shift in Drug Discovery E Rymbai, D Sugumar, D Selvaraj, S Jayaram INTERNATIONAL JOURNAL OF APPLIED PHARMACEUTICAL SCIENCES AND RESEARCH 5 (04 …, 2020 | 1* | 2020 |
| Molecular insights into the potential effects of selective estrogen receptor β agonists in Alzheimer's and Parkinson's diseases E Rymbai, D Sugumar, A Chakkittukandiyil, R Kothandan, D Selvaraj Cell Biochemistry and Function 42 (3), e4014, 2024 | | 2024 |
| A preliminary study to identify existing drugs for potential repurposing in breast cancer based on side effect profile E Rymbai, D Sugumar, PT Krishnamurthy, D Selvaraj, S Vasu, S Priya, ... Drug Research 73 (05), 296-303, 2023 | | 2023 |
| Role of estrogen receptors in cancer: a special emphasis on the therapeutic potential of estrogen receptor β E Rymbai, D Sugumar, D Roy, D Selvaraj Pharmaceutical Sciences Asia 49 (5), 408-424, 2022 | | 2022 |
Divakar SelvarajJ.S.S College of Pharmacy, OotyVerified email at jssuni.edu.in
